Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 8 to 10 amino acid residues in defined sequence
Patent
1993-12-22
1996-01-02
Warden, Jill
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
8 to 10 amino acid residues in defined sequence
530329, 530330, A61K 3800, C07K 500, C07K 700
Patent
active
054809703
ABSTRACT:
Radionuclide chelating compounds are provided for conjugation to targetting molecules such as proteins, peptides or antibodies. The resulting labelled targetting molecules may be used in diagnosis and therapy.
REFERENCES:
patent: 4390528 (1983-06-01), Najjar
patent: 4965392 (1990-10-01), Fritzberg
patent: 4986979 (1991-01-01), Morgan
patent: 5021567 (1991-06-01), Johnson
patent: 5028593 (1991-07-01), Nishioka
patent: 5071965 (1991-12-01), Dunn
patent: 5082930 (1992-01-01), Nicolotti
patent: 5091514 (1992-02-01), Fritzberg
patent: 5112594 (1992-05-01), Woulfe
patent: 5112595 (1992-05-01), Woulfe
patent: 5175257 (1992-12-01), Kasina
patent: 5175343 (1992-12-01), Fritzberg
patent: 5187264 (1993-02-01), Verbruggen
patent: 5196515 (1993-03-01), Lever
patent: 5202109 (1993-04-01), Fritzberg
patent: 5202451 (1993-04-01), Fritzberg
patent: 5220000 (1993-06-01), Theodoropulos
patent: 5248764 (1993-09-01), Flanagan
Nevrath, A. R., Kent, S. B. H., and Strick, N. (1984) J. Virol. Meth. 9, 341-346 "Monoclonal antibodies to hepatitis B surface . . .".
Babich et al J Nucl Med, 1993, 34:2176 "Tchnetium-99m-labeled chemotactic peptides:".
Clarke et al Coordination Chemistry Reviews, 1987, 78:253 "Medical diagnostic imaging with complexes of 99mTc".
Dewanjee et al Seminars in Nuclear Medicine vol XX, No. 1 (Jan.), 1990:5-27 "The chemistry of .sup.99m Tc-labeled radiopharmaceuticals".
Fischman et al J Nucl Med, 1993, 23:2134 "In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates".
Fischman et al J Nuclear Med, 1991, 32(3):483 "Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs".
Fridkin et al Mol Cell Biochem, 1981, 41:73 "Tuftsin, Thr-Lys-Pro-Arg".
McAfee et al Radiology, 1989, 171:593 "Update on radiopharmaceuticals for medical imaging".
Miller J nucl Med, 1993, 34(11):15N "Synthetic peptides come of age".
Olsen J Heterocycl Chem, 1970, 7(2):435 "Synthesis of quinoxaline peptides by the solid phase method".
Paik et al Int J Nucl Med Biol, 1985, 12(1):3 "The labeling of high affinity sites of antibodies with 99m-Tc".
Showell et al J Exp Med, 1976, 143:1154 "The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils".
Kaihara et al Chem Ab, 1961, 13678a "Quinaldylglycyltaurine: a urinary metabolite of quinaldic acid and kynurenic acid in the cat".
Goodbody Anne
Pollak Alfred
Prickril Benet
Resolution Pharmaceuticals
Warden Jill
LandOfFree
Metal chelators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metal chelators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metal chelators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-236016